Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Return on Invested Capital (2022 - 2025)

Atara Biotherapeutics' Return on Invested Capital history spans 4 years, with the latest figure at 0.18% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 107.0% year-over-year to 0.18%; the TTM value through Dec 2025 reached 0.18%, down 107.0%, while the annual FY2025 figure was 0.1%, 8555.0% up from the prior year.
  • Return on Invested Capital reached 0.18% in Q4 2025 per ATRA's latest filing, up from 0.73% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 13.44% in Q3 2023 to a low of 503.25% in Q1 2024.
  • Average Return on Invested Capital over 4 years is 39.33%, with a median of 0.18% recorded in 2025.
  • Peak YoY movement for Return on Invested Capital: tumbled -50046bps in 2024, then skyrocketed 50343bps in 2025.
  • A 4-year view of Return on Invested Capital shows it stood at 1.79% in 2022, then plummeted by -538bps to 11.41% in 2023, then soared by 108bps to 0.89% in 2024, then plummeted by -121bps to 0.18% in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Return on Invested Capital are 0.18% (Q4 2025), 0.73% (Q3 2025), and 0.18% (Q2 2025).